Below is our 2018 Faculty.
Check back at a later date for our complete 2019 Faculty list.
Martin B. Leon, MD
Martin B. Leon, is a Professor of Medicine at Columbia University College of Physicians and Surgeons and Director of the Center for Interventional Vascular Therapy (CIVT) at New York Presbyterian Hospital/Columbia University Medical Center. Dr. Leon was the Founder and Chairman Emeritus of the Cardiovascular Research Foundation (CRF) in New York City and is currently CRF’s Co-Director, Medical Research and Education Division. A distinguished pioneer in interventional cardiovascular medicine, Dr. Leon has been the national principal investigator for over 50 clinical trials that have helped shape the field including STRESS, STARS, Gamma-one, SIRIUS, ENDEAVOR, and most recently, the PARTNER trial, studying the value of transcatheter valve therapy for patients with aortic stenosis.
Gary S. Mintz, MD
Gary S. Mintz, Chief Medical Officer of the Cardiovascular Research Foundation, the Managing Co-Director of Transcatheter Cardiovascular Therapeutics (TCT), and Editor-In-Chief of www.tctmd.com. Dr. Mintz has extensive experience in both interventional cardiology and cardiovascular imaging, in particular intravascular imaging and physiology. He joined the Cardiovascular Research Foundation in 1991 as Director of the Coronary Ultrasound Program that has made fundamental observations about the pathology, pathogenesis, and mechanisms of coronary atherosclerosis, catheter-based interventions, and restenosis. He is the author of almost 1000 articles or book chapters and 800 abstracts concerning various aspects of clinical cardiology, cardiac ultrasound, hemodynamics, cardiac radiology and coronary arteriography, interventional cardiology, and intravascular imaging and physiology. In 2005, Dr. Mintz published the single-authored textbook Intracoronary Ultrasound that has now been translated into Chinese.
Jeffrey W. Moses, MD
An internationally recognized interventional cardiologist, Dr. Moses has performed more than 15,000 interventional procedures, authored over 600 publications, and served as lead investigator for numerous national and international clinical studies that have demonstrated the effectiveness and safety of coronary stent placement. In 2002, Dr. Moses was the lead investigator on a large clinical trial, the first in the U.S. that demonstrated the enormous benefit that led to FDA approval of the first drug-coated stent now used in the majority of interventional procedures in the U.S. Most recently in on the Executive Committee of PARTNER trial; they brought the first transcatheter aortic valve to clinical use in the U.S. He currently serves as Director of Interventional Cardiovascular Therapeutics at Columbia University Medical Center and as Director of Advanced Cardiac Interventions at St Francis Hospital and Heart Center in Roslyn, NY. He is also a pioneer in developing approaches involving minimally invasive surgery, angioplasty, gene therapy, novel imaging technologies and various support devices that allow for wider application of interventional cardiovascular procedures.
Richard A. Shlofmitz, MD, FACC
Richard A. Shlofmitz, is Chairman of Cardiology at St. Francis Hospital, The Heart Center, where he has practiced since 1987. Performing over 1,000 coronary interventions annually, he has one of the largest volumes of experience in PCI. He has the most clinical experience with orbital atherectomy and optical coherence tomography (OCT) world-wide. Dr. Shlofmitz has been one of the largest enrollers for multiple clinical trials, with more than 50 publications in peer-reviewed cardiology journals. Dr. Shlofmitz has worked to advance the field with a focus on Precision PCI. He is a founding co-director of the annual Intravascular Imaging and Physiology Course.
Allen Jeremias, MD, MSc
Allen Jeremias, is the Director of Interventional Cardiology Research and Associate Director of the Cardiac Catheterization Laboratory at St. Francis Hospital, Roslyn, NY. He is also a member of the Cardiovascular Research Foundation, New York, NY where he currently serves as the Director of the Physiology Core Laboratory. He completed his Medical training at The Cleveland Clinic Foundation, Stanford University School of Medicine, as well as Beth Israel Deaconess Medical Center, Harvard Medical School. Dr. Jeremias has numerous publications in the area of coronary physiology and intravascular imaging.
Rasha Al-Lamee, MBBS
Dr. Rasha Al-Lamee is an Interventional cardiology consultant and clinical trialist at Imperial College Healthcare NHS Trust, London. Her research interests are complex coronary intervention, coronary physiology, and invasive intravascular assessment. She designed, conducted and led the ORBITA trial and is lead author of the The Lancet publication. She has authored over 40 peer-reviewed publications. She studied at Oxford University and University College, London, and completed the North West London Cardiology specialist training rotation. She completed Interventional Fellowship training at the Hammersmith Hospital and completed an International Fellowship in Milan with Professor Antonio Colombo.
Ziad Ali, MD, PhD
Dr. Ali is Assistant Professor of Medicine at Columbia University Medical Center where he serves as the Director of Intravascular Imaging and Physiology and Director of the Cardio-renal program. He is also the Director of the Angiographic Core Laboratory at Cardiovascular Research Foundation. Dr. Ali is the Global PI of the International Multicenter Randomized Controlled Trials ILUMIEN III and IV. Dr. Ali pioneered techniques to perform diagnostic angiography with ultra-low contrast volumes and performed interventions without contrast administration, protecting patients with advanced kidney disease from the need for dialysis.
Ori Ben-Yehuda, MD, FACC
Ori Ben-Yehuda, is the Executive Director of the Clinical Trials Center at the Cardiovascular Research Foundation. A graduate of Tel Aviv University, he completed his fellowship in cardiology at the University of California, San Diego. From 1997 to 2011 he was the Director of the Coronary Care Unit at UCSD where he was also Professor of Medicine. He also served as the Deputy Editor of the Journal of the American College of Cardiology and is presently the Deputy Editor of Structural Heart: the Journal of the Heart Team. Dr. Ben-Yehuda is involved in the design and execution of multiple clinical trials in interventional cardiology.
Andrew Berke, MD
Dr. Berke has been an interventional cardiologist at St. Francis Hospital for 30 years. He received his medical degree at Brown University. His postgraduate medical, cardiology, and interventional cardiology training were all at New York Presbyterian-Columbia, where he was also a full-time faculty member before entering private practice. He has been at the forefront of advances in interventional cardiology. His research interests and publications have spanned the gamut from TIMI to TAVI. He is looking forward to participating in future studies of intravascular imaging, integration of non-invasive modalities into the catheterization laboratory, and furthering catheter-based treatments for structural heart disease. He is a Fellow of the American College of Physicians, a Fellow of the American College of Cardiology, and a Fellow of the Society of Coronary Angiography and Interventions.
Hiram Bezerra, MD, PhD
Hiram Bezerra, is Director, Cardiovascular Imaging Core Laboratory as well as Director, Cardiac Catheterization Laboratory at University Hospital Cleveland Medical Center. He is also an Associate Professor, Medicine at Case Western Reserve University School of Medicine. Previously, he served at Massachusetts General Hospital with extensive expertise in Cardiac Imaging, Interventional Cardiology, Optical Coherence Tomography and Computed Tomography.
Jane Cao, MD, MPH, FACC
Jane Cao, is St. Francis Hospital’s Director of Research and Cardiac Imaging. She is a nationally renowned cardiac imaging specialist and researcher. Dr. Cao received her degree from the Medical College of Fudan University in Shanghai, and completed her Residency in Internal Medicine and Fellowship in Cardiology at the University of Vermont. She earned a Master’s Degree in Biology at Smith College in Massachusetts, and an MPH at the Harvard School of Public Health. Prior to coming to St. Francis, Dr. Cao was a Senior Research Fellow at the National Institutes of Health. She has lectured extensively in both the U.S. and China on cardiac CT and MRI.
Javier Escaned, MD, PhD, FESC
Professor Javier Escaned is Head of the Interventional Cardiology Section and Associate Professor at the Cardiology Department, Hospital Clinico San Carlos (Madrid, Spain), and Complutense University of Madrid. He has over 25 years of clinical experience in interventional cardiology, and trained as a cardiologist the United Kingdom and The Netherlands. He is author of more than 300 scientific articles (H-index 49). Recent multicentre trials in which he has a principal investigator role include ADVISE II, SYNTAX II, and DEFINE-FLAIR. He is editor of two large textbooks, “Coronary Stenosis. Imaging, Structure and Physiology” (PCR Books, Patrick W Serruys co-editor) and “Physiological Assessment of Coronary Stenoses and the Microcirculation” (Springer, Justin Davies, co-editor). Additional interest are philosophy and music.
Cindy Grines, MD
One of the nation’s preeminent cardiologists, Cindy Grines, MD is a renowned researcher who pioneered primary percutaneous coronary intervention (PCI) for heart attacks. She has a long history of research, publications and clinical trial design with more than 400 publications, numerous book chapters and review chapters. Dr. Grines serves on the editorial boards of several major journals, nationally and internationally, and she has co-edited several medical handbooks. She is editor-in-chief of the Journal of Interventional Cardiology.
Giulio Guagliumi, MD
Dr. Giulio Guagliumi is leading the Research Program at Interventional Cardiology, Ospedale Papa Giovanni XXIII Bergamo, Italy. He was trained with Master in Interventional Cardiology at the Clinique Pasteur, Toulouse, France and awarded at Mayo Clinic and St. Mary Hospital, Rochester in imaging and coronary physiology assessment of vascular response to intracoronary stents. He has authored 230 peer-reviewed publications in cardiovascular research and clinical trials across all prestigious cardiology journals. He is a member of the executive board of EAPCI. In 2014, he was listed among the most highly cited cardiology doctors by Thomson Reuters.
Jonathan Hill, MD
Jonathan Hill, MD, FRCP is director of the Cardiac Catheterization Laboratories at King’s College Hospital. His primary focus is on complex interventional procedures especially chronic total occlusion and percutaneous left ventricular support. At King’s he has developed an active clinical research programme using optical coherence tomography and is a strong advocate for a universal intravascular imaging approach to guide percutaneous intervention. He is a graduate of Cambridge and Edinburgh Universities, graduating in 1992. He trained in cardiology at The London Chest and St. Bartholomew’s Hospitals. In 1999 he was awarded the first National Heart Lung and Blood Institute Bench to Bedside award and trained in basic science and interventional research within the Cardiovascular Branch of the National Institutes of Health in Bethesda. He undertook a research program relating to stem and progenitor cells in cardiovascular disease with a particular interest in vascular repair. He completed his interventional cardiology training at the London Chest Hospital. In 2005, he was appointed as Clinical Senior Lecturer and Consultant Cardiologist at King’s College London. He is a member of the steering committee of the Illumien IV trial.
Cezar Iliescu, MD, FACC, FSCAI
Dr. Iliescu Is an interventional cardiologist interested in vascular biology in cancer patients, endovascular treatment of patients with chronic thrombocytopenia, physiologic assessment of coronary stenosis, treatment of radiation-induced cardiovascular disease. Currently, he is the Director of the Cardiac Catheterization Laboratory, Department of Cardiology, The University of Texas MD Anderson Cancer Center.
Dimitrios Karmpaliotis, MD, PhD
Dr. Karmpaliotis is a member of the Center for Interventional Vascular Therapy at Columbia University Medical Center. Dr. Karmpaliotis specializes in advanced, complex coronary intervention. He brings a wealth of experience in percutaneous coronary interventions. Dr. Karmpaliotis graduated from the University of Athens School of Health Sciences and trained at the prestigious Beth Israel Deaconess Medical Center at Harvard Medical School. Dr. Karmpaliotis was instrumental in building a world-class interventional cardiology program at Piedmont Heart Center in Atlanta, Georgia and has contributed to building one of the largest complex PCI programs in the world at CUMC. He also serves as the co-director of the US CTO Summit Dr. Karmpaliotis has served as principal investigator on more than 50 clinical trials, with special interest in the development of techniques for treating chronic total occlusions in coronary arteries.
Morton Kern, MD
Dr. Kern is Chief of Medicine, VA Long Beach Health Care System, Professor of Medicine, University California, Irvine. He continues to perform and teach cardiac catheterization and PCI. Dr. Kern is ABIM Certified in Internal Medicine, Cardiovascular Diseases and Interventional Cardiology and is a past president and now a Master Fellow of the SCAI. His research interests in coronary blood flow, intravascular physiology, intravascular ultrasound, vulnerable plaque and evaluation of cardiovascular hemodynamics. He has authored several textbooks, notably The Cardiac Catheterization Handbook, 6th ed. and its companion The Interventional Cardiac Cath Handbook, 4th ed.
Ajay Kirtane, MD, SM
Ajay J. Kirtane, MD, SM, is Associate Professor of Medicine at Columbia University Medical Center (CUMC) and Director of the Cardiac Catheterization Laboratories at New York Presbyterian (NYP) Hospital / CUMC. Dr. Kirtane is a graduate of Princeton University and Columbia University College of Physicians and Surgeons, and completed his residency/chief residency in Internal Medicine at the University of California, San Francisco. He completed fellowships in Cardiovascular Disease and Coronary and Peripheral Vascular Intervention at Beth Israel Deaconess Medical Center / Harvard Medical School and has a Masters of Science in Clinical Epidemiology from the Harvard School of Public Health.
Michael S. Lee, MD, FACC, FSCAI
Dr. Michael S. Lee, is an interventional cardiologist, Associate Professor of Medicine and the Associate Director of Interventional Cardiology Research at the UCLA Medical Center. Dr. Lee has published over 110 (over 70 of which were as first author) peer reviewed articles and chapters. He has also published on topics including antithrombotic therapy in patients with acute coronary syndrome and in percutaneous coronary intervention, protocols to establish heparin dosing regimens, and percutaneous coronary intervention for the treatment of left main disease, saphenous vein grafts, and cardiac allograft vasculopathy who have undergone orthotopic heart transplantation. He is one of the world’s authorities in coronary and peripheral orbital atherectomy.
Andrew Lituchy, MD
Andrew E. Lituchy, MD, FACC, is a clinical interventional cardiologist at St. Francis Hospital in Roslyn, New York. He completed his general and interventional cardiology fellowship training in 1995 at New York Hospital/Cornell Medical Center. Prior to that, he completed an internship and residency in internal medicine at Jacoby Medical Center in the Bronx. Dr. Lituchy has performed more than 10,000 diagnostic and 4,000 interventional procedures. He is a Fellow, American College of Cardiology and Instructor in Medicine, Cornell University College of Medicine.
Akiko Maehara, MD
Dr. Maehara is the Director of the Intravascular Imaging Core Laboratory at the CRF Clinical Trials Center. She is also an Assistant Professor of Medicine at Columbia University College of Physicians and Surgeons in New York. She is a leading authority in the field of intravascular imaging and physiology. Dr. Maehara received her medical degree from Yamaguchi University School of Medicine in Yamaguchi, Japan. She completed her cardiovascular fellowship at the Cardiovascular Center in Toranomon Hospital in Tokyo. Dr. Maehara finished a research fellowship at Stanford University and at the Washington Hospital Center in Washington, DC.
Thomas Pappas, MD
Thomas Pappas, is Director of St. Francis Hospital’s Cardiac Catheterization Laboratory. In this capacity, he has participated in numerous clinical trials evaluating novel coronary interventional devices. He is a graduate of Cornell University Medical College, practicing both interventional as well as consultative cardiology for the past 25 years at St. Francis Hospital. Dr. Pappas has consistently been recognized by Newsday and Castle Connolly as one of the top physicians on Long Island and has been selected as one of New York magazine’s Best Doctors.
George Petrossian, MD
George Petrossian, is a board certified cardiologist and interventional cardiologist who has been a Principal Investigator for a number of nationwide studies that have transformed the treatment of heart disease. His pioneering research helped win FDA approval of CoreValve, a minimally invasive device that offers new hope for patients with aortic stenosis too frail to undergo open heart surgery.
Johan Svanerud, MSc.
Johan Svanerud, is the Founder and CEO of Coroventis Research, a startup device company focused on innovative solutions for advanced coronary physiology. Mr. Svanerud is a pioneer in technologies for physiologic lesion assessment with a background in Radi Medical Systems, the Swedish Company that invented the PressureWire.
Evelyn Regar, MD, PhD, FESC
Evelyn Regar, is currently engaged as Consultant Director of Research with the Department of Cardiovascular Surgery at the University Hospital of Zürich, Switzerland. Prior to that she spent several years as a interventional cardiologist at the ThoraxCenter of the Erasmus Medical Center in The Netherlands. Dr. Regar did her preclinical studies at the University of Regensburg, Germany, before training at the Technical University of Munich. From there, she trained in internal medicine and cardiology at the University Hospital, also in Munich. She has authored of more than 300 original articles in peer-reviewed major scientific journals, as well as several books and book chapters.
Newell Robinson, MD
Newell Robinson, is a board certified cardiothoracic surgeon who has been recognized nationally for his expertise in minimally-invasive cardiac surgery. As Co-Principal Investigator of the CoreValve clinical study, his published findings, helped gain FDA approval of the device. Dr. Robinson has also been pivotal in bringing state-of-the-art technology to St. Francis Hospital, including a hybrid OR that allows interventional cardiologists and cardiothoracic surgeons to work side by side for the benefit of patients. Dr. Robinson is consistently cited on New York magazine’ Best Doctors list, in addition to being rated among the top physicians in the country by Castle Connolly.
Paul Teirstein, MD
Paul Teirstein, MD, is the Chief of Cardiology and Director of Interventional Cardiology for Scripps Clinic and Director of the Scripps Prebys Cardiovascular Institute for Scripps Health. With a primary focus on complex coronary interventions and new technology development, Dr. Teirstein has played an active role in the initial development and clinical investigation of coronary stent procedures, rotablator atherectomy, coronary angioscopy and the utilization of cardiopulmonary support. Dr. Teirstein pioneered the first effective treatment for restenosis (low dose radiation therapy) and was one of the early investigators of medicated and bioabsorbable stents. Recent areas of investigation include new technology for minimally invasive transcatheter aortic valve replacement (TAVR). Dr. Teirstein currently performs in excess of 800 stent procedures per year and maintains an active clinical research and teaching unit at Scripps Clinic where he strives to offer patients the most advanced cardiovascular care available worldwide.
Ron Waksman, MD, FACC
Ron Waksman, MD, FACC, Associate Director, Division of Cardiology, MedStar Washington Hospital Center (MWHC) and Director of Cardiovascular Research and Advanced Education for the MedStar Heart and Vascular Institute at the MedStar Washington Hospital Center. With nearly 20 years of experience in leading edge medical technologies, Dr. Waksman is a world-renowned interventional cardiologist and is a highly sought after Principal Investigator for pre-clinical and clinical studies conducted in the United States and abroad. Dr Waksman has performed over 5000 coronary interventions throughout his career.
Giora Weisz, MD
Dr. Weisz is director of the interventional cardiology program at Montefiore Medical Center in New York and faculty of the Cardiovascular Research Foundation. Dr. Weisz is a recognized researcher focused on innovative technologies. He has pioneered the use robotic-enhanced PCI, navigation, and positioning technologies. Dr. Weisz has been the Principal Investigator for pivotal clinical studies in these fields, and led multicenter studies in interventional imaging and the combination of PCI with pharmacological anti-ischemic treatment. Dr. Weisz has published extensively in the most prestigious peer-review medical journals.